1. Home
  2. PATK vs ARQT Comparison

PATK vs ARQT Comparison

Compare PATK & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

HOLD

Current Price

$69.30

Market Cap

2.7B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$26.77

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PATK
ARQT
Founded
1959
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
PATK
ARQT
Price
$69.30
$26.77
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
★ $122.75
$34.00
AVG Volume (30 Days)
488.4K
★ 2.4M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
★ 2.02%
N/A
EPS Growth
N/A
★ 88.79
EPS
★ 2.37
0.03
Revenue
$29,000,000.00
★ $376,072,000.00
Revenue This Year
$5.78
$34.85
Revenue Next Year
$6.51
$29.39
P/E Ratio
★ $28.84
$895.00
Revenue Growth
★ 262.50
91.34
52 Week Low
$67.00
$19.30
52 Week High
$148.50
$31.77

Technical Indicators

Market Signals
Indicator
PATK
ARQT
Relative Strength Index (RSI) 30.85 56.25
Support Level N/A $24.91
Resistance Level $89.83 $28.20
Average True Range (ATR) 2.30 1.45
MACD -0.10 0.30
Stochastic Oscillator 12.91 72.25

Price Performance

Historical Comparison
PATK
ARQT

About PATK Patrick Industries Inc.

Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: